International Private Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$600K Buy
21,378
+3,117
+17% +$83K 0.37% 61
2025
Q4
$455K Sell
18,261
-107
-0.6% -$2.7K 0.29% 73
2025
Q3
$468K Sell
18,368
-2,312
-11% -$57.1K 0.29% 74
2025
Q2
$501K Buy
20,680
+8,940
+76% +$208K 0.43% 56
2025
Q1
$298K Sell
11,740
-3,442
-23% -$90.1K 0.29% 107
2024
Q4
$403K Buy
15,182
+578
+4% +$15.7K 0.4% 66
2024
Q3
$423K Sell
14,604
-705
-5% -$20.6K 0.62% 40
2024
Q2
$428K Buy
+15,309
New +$421K 0.72% 32

Other funds holding PFE

International Private Wealth Advisors's PFE Position: Q1 2026 in Review

International Private Wealth Advisors increased its Pfizer (PFE) stake by 17% in Q1 2026, buying an estimated $83K and bringing the position to 21,378 shares worth $600K. The position accounts for 0.37% of the portfolio, ranked #61.

International Private Wealth Advisors first reported a position in PFE in Q2 2024 and has held it in 8 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • International Private Wealth Advisors held 21,378 shares of Pfizer worth $600K as of Q1 2026.
  • International Private Wealth Advisors bought 3,117 Pfizer shares in Q1 2026, an estimated $83K.
  • Pfizer made up 0.37% of International Private Wealth Advisors's portfolio in Q1 2026, its #61 holding.
  • International Private Wealth Advisors first reported a position in Pfizer in Q2 2024 and has held it in 8 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on International Private Wealth Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.